Skip to contentLucera Erick — AIT Therapeutics, Inc. insider: 80 transactions · InsiderLensLucera Erick
- EVP, CHIEF FINANCIAL OFFICER at Editas Medicine, Inc. · on record since May 18, 2023
- Director at JJ&R Ventures, Inc. · on record since Apr 5, 2023
- Chief Financial Officer at DYNEGY INC /IL/ · on record since Apr 3, 2026
- See Remarks at Valera Pharmaceuticals Inc · on record since May 23, 2017
- Director at AIT Therapeutics, Inc. · on record since Apr 30, 2018
- Chief Financial Officer at AVEO PHARMACEUTICALS INC · on record since Jan 8, 2020
- Director at AFH ACQUISITION X, INC. · on record since Oct 21, 2021
Insider trading activity of Lucera Erick
- Transactions on record
- 80
- since Mar 27, 2017
- Open-market buys
- 5
- $66.8K
- Open-market sells
- 5
- $265.7K
- Companies traded
- 7
- last filing Jun 26, 2026
Figures computed from official regulatory filings — methodology.
Companies where Lucera Erick has traded
- DYNEGY INC /IL/7 tx · $133.3K · Jun 26, 2026
- JJ&R Ventures, Inc.3 tx · Dec 18, 2025
- AIT Therapeutics, Inc.44 tx · $39.3K · Nov 6, 2025
- Editas Medicine, Inc.9 tx · $132.3K · Mar 27, 2025
- AFH ACQUISITION X, INC.4 tx · Sep 20, 2023
- AVEO PHARMACEUTICALS INC6 tx · Jan 19, 2023
- Valera Pharmaceuticals Inc7 tx · $37.4K · Mar 8, 2019
Track record of Lucera Erick
Statistical track record
Free- Open-market buys
- 7
- Last buy
- Aug 14, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Lucera Erick
Co-insiders of Lucera Erick
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
AFH Holding & Advisory, LLCAFH ACQUISITION X, INC.
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 26, 2026 | Sell | -2,362 | 20.37 USD | — | SEC |
| May 14, 2026 | Sell | -1,448 | 18.36 USD | $26.6K | SEC |
| Apr 3, 2026 | Sell | -5,727 | 18.64 USD | $106.8K | SEC |
| Feb 17, 2026 | AwardD | 105,000 | 0.00 USD | $0 | SEC |
| Feb 17, 2026 | Award | 65,000 | 0.00 USD | $0 | SEC |
| Dec 18, 2025 | AwardD | 150,000 | 0.00 USD | $0 | SEC |
| Nov 6, 2025 | AwardD | 3,750 | — | — | SEC |
| Nov 6, 2025 | AwardD | 1,250 | — | — | SEC |
| Nov 6, 2025 | OtherD | -2,250 | — | — | SEC |
| Nov 6, 2025 | OtherD | -1,500 | — | — | SEC |
| Nov 6, 2025 | OtherD | -1,250 | — | — | SEC |
| Nov 6, 2025 | OtherD | -1,000 | — | — | SEC |
| Nov 6, 2025 | OtherD | -3,750 | — | — | SEC |
| Nov 6, 2025 | AwardD | 1,500 | — | — | SEC |
| Nov 6, 2025 | AwardD | 1,250 | — | — | SEC |
| Nov 6, 2025 | AwardD | 2,000 | — | — | SEC |
| Nov 6, 2025 | AwardD | 2,250 | — | — | SEC |
| Nov 6, 2025 | AwardD | 1,250 | — | — | SEC |
| Nov 6, 2025 | OtherD | -1,250 | — | — | SEC |
| Nov 6, 2025 | AwardD | 1,000 | — | — | SEC |
| Nov 6, 2025 | OtherD | -2,000 | — | — | SEC |
| Nov 6, 2025 | OtherD | -1,250 | — | — | SEC |
| Apr 1, 2025 | Award | 66,100 | 0.00 USD | $0 | SEC |
| Apr 1, 2025 | AwardD | 214,500 | 0.00 USD | $0 | SEC |
| Mar 28, 2025 | AwardD | 75,000 | 0.00 USD | $0 | SEC |